SBC Medical [SBC] vs Equifax [EFX] Detailed Stock Comparison
SBC Medical
NASDAQ
Loading...
Equifax
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: SBC Medical wins in 14 metrics, Equifax wins in 5 metrics, with 0 ties. SBC Medical appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | SBC Medical | Equifax | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 9.17 | 46.75 | SBC Medical |
| Price-to-Book Ratio | 2.01 | 5.82 | SBC Medical |
| Debt-to-Equity Ratio | 6.23 | 93.55 | SBC Medical |
| PEG Ratio | 0.42 | 25.48 | SBC Medical |
| EV/EBITDA | 3.82 | 18.98 | SBC Medical |
| Profit Margin (TTM) | 24.94% | 10.95% | SBC Medical |
| Operating Margin (TTM) | 51.14% | 20.22% | SBC Medical |
| EBITDA Margin (TTM) | 51.14% | 20.22% | SBC Medical |
| Return on Equity | 26.19% | 12.76% | SBC Medical |
| Return on Assets (TTM) | 19.98% | 5.80% | SBC Medical |
| Free Cash Flow (TTM) | $17.17M | $813.00M | Equifax |
| Dividend Yield | N/A | 0.46% | N/A |
| 1-Year Return | -60.14% | -13.87% | Equifax |
| Price-to-Sales Ratio (TTM) | 2.28 | 5.06 | SBC Medical |
| Enterprise Value | $337.81M | $34.53B | Equifax |
| EV/Revenue Ratio | 1.71 | 5.91 | SBC Medical |
| Gross Profit Margin (TTM) | 79.73% | 56.76% | SBC Medical |
| Revenue per Share (TTM) | $2 | $47 | Equifax |
| Earnings per Share (Diluted) | $0.48 | $5.13 | Equifax |
| Beta (Stock Volatility) | 1.27 | 1.64 | SBC Medical |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
SBC Medical vs Equifax Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| SBC Medical | 4.02% | 5.26% | -9.47% | 35.80% | -14.23% | -20.72% |
| Equifax | -0.87% | -0.08% | -9.22% | -11.56% | -5.18% | -4.51% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| SBC Medical | -60.14% | -60.14% | -60.14% | -80.77% | -99.99% | -99.99% |
| Equifax | -13.87% | 7.86% | 45.57% | 129.53% | 694.07% | 603.46% |
Performance & Financial Health Analysis: SBC Medical vs Equifax
| Metric | SBC | EFX |
|---|---|---|
| Market Information | ||
| Market Cap | $451.91M | $29.54B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 32,970 | 1,042,150 |
| 90 Day Avg. Volume | 137,307 | 1,099,837 |
| Last Close | $4.40 | $239.81 |
| 52 Week Range | $2.62 - $12.50 | $199.98 - $309.63 |
| % from 52W High | -64.80% | -22.55% |
| All-Time High | $49,900.00 (Jun 21, 2010) | $309.63 (Sep 16, 2024) |
| % from All-Time High | -99.99% | -22.55% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.14% | 0.07% |
| Quarterly Earnings Growth | 0.15% | 0.17% |
| Financial Health | ||
| Profit Margin (TTM) | 0.25% | 0.11% |
| Operating Margin (TTM) | 0.51% | 0.20% |
| Return on Equity (TTM) | 0.26% | 0.13% |
| Debt to Equity (MRQ) | 6.23 | 93.55 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $2.19 | $41.22 |
| Cash per Share (MRQ) | $1.28 | $1.53 |
| Operating Cash Flow (TTM) | $18.83M | $1.39B |
| Levered Free Cash Flow (TTM) | $25.84M | $864.12M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.46% |
| Last 12-Month Dividend | N/A | $1.17 |
Valuation & Enterprise Metrics Analysis: SBC Medical vs Equifax
| Metric | SBC | EFX |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 9.17 | 46.75 |
| Forward P/E | 0.42 | 25.48 |
| PEG Ratio | 0.42 | 25.48 |
| Price to Sales (TTM) | 2.28 | 5.06 |
| Price to Book (MRQ) | 2.01 | 5.82 |
| Market Capitalization | ||
| Market Capitalization | $451.91M | $29.54B |
| Enterprise Value | $337.81M | $34.53B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.71 | 5.91 |
| Enterprise to EBITDA | 3.82 | 18.98 |
| Risk & Other Metrics | ||
| Beta | 1.27 | 1.64 |
| Book Value per Share (MRQ) | $2.19 | $41.22 |
Financial Statements Comparison: SBC Medical vs Equifax
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | SBC | EFX |
|---|---|---|
| Revenue/Sales | $47.33M | $1.44B |
| Cost of Goods Sold | $9.60M | $656.70M |
| Gross Profit | $37.73M | $785.30M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $24.20M | $235.80M |
| EBITDA | $23.34M | $414.70M |
| Pre-Tax Income | $31.45M | $185.40M |
| Income Tax | $9.96M | $51.60M |
| Net Income (Profit) | $21.49M | $133.80M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | SBC | EFX |
|---|---|---|
| Cash & Equivalents | $132.06M | $195.20M |
| Total Current Assets | $215.10M | $1.48B |
| Total Current Liabilities | $48.47M | $1.73B |
| Long-Term Debt | $8.32M | $4.32B |
| Total Shareholders Equity | $226.32M | $5.11B |
| Retained Earnings | $210.97M | $6.10B |
| Property, Plant & Equipment | $5.67M | $285.10M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | SBC | EFX |
|---|---|---|
| Operating Cash Flow | $22.95M | $223.90M |
| Capital Expenditures | $-431,559 | N/A |
| Free Cash Flow | $1.17M | $116.70M |
| Debt Repayment | $-279,327 | $-48.10M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | SBC | EFX |
|---|---|---|
| Shares Short | 224,327 | 2.42M |
| Short Ratio | 1.34 | 2.45 |
| Short % of Float | 0.02% | 0.02% |
| Average Daily Volume (10 Day) | 32,970 | 1,042,150 |
| Average Daily Volume (90 Day) | 137,307 | 1,099,837 |
| Shares Outstanding | 102.75M | 123.95M |
| Float Shares | 5.06M | 123.19M |
| % Held by Insiders | 0.90% | 0.01% |
| % Held by Institutions | 0.00% | 1.01% |
Dividend Analysis & Yield Comparison: SBC Medical vs Equifax
| Metric | SBC | EFX |
|---|---|---|
| Last 12-Month Dividend | N/A | $1.17 |
| Last 12-Month Dividend Yield | N/A | 0.46% |
| 3-Year Avg Annual Dividend | N/A | $1.30 |
| 3-Year Avg Dividend Yield | N/A | 0.17% |
| 3-Year Total Dividends | N/A | $3.90 |
| Ex-Dividend Date | N/A | Feb 21, 2025 |